Redeye comments on Surgical Science announcing an opportunistic bolt-on deal by offering to acquire ...
Redeye comments on Egetis investor day yesterday, that focused on the commercialization of Emcitate ...
The divestment price estimate of Enersense’s wind power portfolio (2.
Förra veckan aviserade kontraktstillverkaren Hanza förvärvet av finska Leden Group, en ledande kontr...
New defence order from BAE Systems worth SEK 53m Additional order from Denmark also expected near-te...
Obducat AB (publ) meddelade den 18 december 2024 att Obducats dotterbolag Obducat Europe GmbH har er...
I torsdags aviserade industrikoncernen AGES Industri pågående diskussioner kring en eventuell fusion...
Redeye comments on a new additional supplier of Terbinafine that already holds an EU certificate of ...
Redeye leaves a comment following Lipum’s announcement of a grant from Eurostars.
Titania meddelade den 17 december år 2024 att bolaget har tecknat ett avtal om förvärv av fastighete...
Redeye comments on the successful directed share issue of NOK100m and EUR1m primary bid offering.
Alisa Bank issued a profit warning for 2024, lowering expectations for total income and profitabilit...
Redeye initiates coverage of Safello, a Swedish cryptocurrency brokerage founded in 2013 that has ce...
Today (16 December), Elanders announced that it has implemented structural measures regarding its ro...
Mendus continues to make headway with its lead programme assessing cancer vaccine vididencel as a po...
Surprising Q4 PW and CEO resignation, but likely two isolated events Volatile systems business behin...
Redeye comments on Lipigon's change of CEOs.
Addlife ökade omsättningen med 1% (3% organiskt) till 2 344 MSEK under tredje kvartalet, jämfört med...
Pharma Equity Group (“PEG” or “the Company”) announced on Friday, December the 13th, the board of di...
Redeye leaves a short comment on Stille following the company's announcement that the CEO will resig...
